NextSeq 2000 at the Centre for Applied Medical Research University of Navarre (CIMA-UNAV)

April 4, 2025

Discover how the CIMA Institute in Pamplona, Spain, is leveraging the power of the Illumina NextSeq 2000 with XLEAP-SBS Chemistry to advance their genomic research. As a core laboratory in this video we highlight the institute’s innovative approach to sequencing, the impact on the research projects they support and how Illumina’s cutting-edge technology is driving breakthroughs genomics. LinkedIn: https://www.linkedin.com/company/illumina X: https://x.com/illumina Instagram: https://www.instagram.com/illuminainc/ Facebook: https://www.facebook.com/illuminainc TikTok: https://www.tiktok.com/@illuminainc

Share this article on    
    
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.